reports
Man Group PLC : Form 8.3 - Redrow plc
Man Group PLC : Form 8.3 - Redrow plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this for...
Transense Technologies: 4 directors
Four Directors at Transense Technologies bought 41,858 shares at between 100p and 102p. The significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
Brookfield Infrastructure Reports First Quarter 2024 Results
Brookfield Infrastructure Reports First Quarter 2024 Results BROOKFIELD, NEWS, May 01, 2024 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the first quarter ended March 31, 2024. “The benefits of inflation indexation, better than expected economic activity and strong contributions from new investments have favorably impacted our financial results,” said Sam Pollock, Chief Executive Officer of Brookfield Infrastructure Partners. “With the base business performing well...
Stantec acquires Hydrock, a UK integrated engineering design firm
Stantec acquires Hydrock, a UK integrated engineering design firm The acquisition immediately grows Stantec’s workforce in the United Kingdom by more than 30 percent, while extending and diversifying its expertise EDMONTON, Alberta and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- TSX, NYSE: STN , a global leader in sustainable design and engineering, has acquired Hydrock, a 950-person integrated engineering design firm headquartered in Bristol, England. Founded in 1995, Hydrock holds a nationwide presence with 22 UK locations and industry-renowned experience providing sustainable solutions...
Universal Stainless Reports Near-Record Sales and Profitability in Fir...
Universal Stainless Reports Near-Record Sales and Profitability in First Quarter of 2024 Q1 2024 Sales of $77.6 million vs. record $79.8 million in Q4 2023; up 18% from Q1 2023Q1 2024 Gross Margin reaches 18.9% of sales, highest since Q1 2012, despite $1.3 million raw material headwindQ1 2024 Net Income up 59% from Q4 2023 to $4.1 million, or $0.43 per diluted share Cash flow from operations totals $10.3 million, up 39% from Q4 2023 Backlog increases to $325 million on strong order entry BRIDGEVILLE, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasda...
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securi...
Transocean Ltd. Announces Consent Solicitation for 8.375% Senior Secur...
Transocean Ltd. Announces Consent Solicitation for 8.375% Senior Secured Notes due 2028 STEINHAUSEN, Switzerland, May 01, 2024 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) announced today that its wholly owned and indirect subsidiary, Transocean Titan Financing Limited (the “Company” and, together with Transocean Ltd., “Transocean”), is soliciting consents (“Consents” and, such solicitation being referred to herein as, the “Consent Solicitation”) from holders (the “Holders”) of its outstanding 8.375% Senior Secured Notes due 2028 (the “Notes”) as of 5:00 p.m. New York City time, on Apr...
Man Group PLC : Form 8.3 - Quanex Building Products Corporation
Man Group PLC : Form 8.3 - Quanex Building Products Corporation FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose re...
Man Group PLC : Form 8.3 - Tyman plc
Man Group PLC : Form 8.3 - Tyman plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form...
EQS-News: Immunic, Inc. to Announce Financial Results for the First Qu...
Issuer: Immunic AG / Key word(s): Miscellaneous Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update 01.05.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update – Webcast to be Held at 8:00 am ET on May 8, 2024 – NEW YORK, May 1, 2024 – (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therap...
Beijing Comens New Materials Co Ltd: 1 director
A director at Beijing Comens New Materials Co Ltd maiden bought 223,500 shares at 7.130CNY and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
Aveanna to Participate at the RBC Capital Markets Global Healthcare Co...
Aveanna to Participate at the RBC Capital Markets Global Healthcare Conference ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the RBC Capital Markets Global Healthcare Conference in New York on May 14, 2024. Management will host 1x1 investor meetings as well as a fireside chat at 10:30 a.m. Eastern Time on the same day, May 14, 2024. Interested investors and other parties may also listen to a simultaneous webcast of the fireside chat by logging onto the Investor Relations section o...
G1 Therapeutics Provides First Quarter 2024 Financial Results and Oper...
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights - Achieved $14.1 Million in Net Revenue from Sales of COSELA® (trilaciclib) for First Quarter 2024 - - Reaffirmed 2024 Net COSELA Revenue Guidance of $60 to $70 Million - - Announced That Updated Efficacy Results from Phase 2 Trial of Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC) Will Be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - - Announced That Final Analysis of Phase 3 PRESERVE 2 Trial Evaluating Overall Survival in 1L Metastatic Tri...
Hui Lyu Ecological Technology Groups Co. Ltd: 4 directors
Four Directors at Hui Lyu Ecological Technology Groups Co. Ltd bought 973,400 shares at between 3.670CNY and 3.770CNY. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all th...
Kuehne + Nagel International AG: 1 director
A director at Kuehne + Nagel International AG bought 40,000 shares at 243.710CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
Menhaden Resource Efficiency: 1 director
A director at Menhaden Resource Efficiency bought 412,500 shares at 104p and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies t...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine post-surgery medication use, rates of hospitalization and adverse events of standard BPH treatments -Teleflex unveils latest advancements in BPH treatment with UroLift™ 2 System with Advanced Tissue Control (ATC) designed to treat all prostate types -...
Bombardier confirmera que les objectifs pour 2025 sont en bonne voie e...
Bombardier confirmera que les objectifs pour 2025 sont en bonne voie et présentera en détail les leviers de croissance jusqu’en 2030 dans le cadre de la Journée des investisseurs 2024 Avec un plan de redressement impressionnant déjà en action, Bombardier maintient clairement dans sa mire la réalisation des objectifs pour 2025Les leviers de croissance de 2025 à 2030 seront axés sur les améliorations continues de produits et sur les segments opérationnels au solide ratio de rendement du capital investi (RCI)Des flux de revenus diversifiés construisent une fondation basée sur la résilience et ...
Brookfield and Microsoft Collaborating to Deliver Over 10.5 GW of New ...
Brookfield and Microsoft Collaborating to Deliver Over 10.5 GW of New Renewable Power Capacity Globally First of its kind global framework agreement will accelerate the expansion of renewable energy capacity to contribute to Microsoft’s sustainability goalsThe five-year agreement outlines plans for the development of over 10.5 gigawatts of new renewable energy capacity, almost eight times larger than the largest single corporate PPA ever signediPotential to expand the framework scope and development capacity within the target regions of the U.S. and Europe, and beyond to Asia-Pacific, India...
Tower Semiconductor to Participate in the 52nd Annual JP Morgan Global...
Tower Semiconductor to Participate in the 52nd Annual JP Morgan Global Technology, Media, and Communications Conference MIGDAL HAEMEK, Israel, May 01, 2024 – Tower Semiconductor (NASDAQ/TASE: TSEM), the leading foundry of high-value analog semiconductor solutions, today announced that its Chief Executive Officer, Russell Ellwanger, will participate in the 52nd Annual JP Morgan Global Technology, Media, and Communications Conference on Monday, May 20 and Tuesday, May 21. The conference will take place at The Westin Boston Seaport District Hotel in Boston. Mr. Ellwanger will participate in a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.